AMYRIS, Inc. (AMRS) Misses Q1 EPS by 36c

AMYRIS, Inc. (NASDAQ: AMRS) reported Q1 EPS of ($1.02), $0.36 worse than the analyst estimate of ($0.66). Revenue for the quarter came in at $21.5 million versus the consensus estimate of $45.03 thousand.

For earnings history and earnings-related data on AMYRIS, Inc. (AMRS) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Bio-key International, Inc. (BKYI) Tops Q2 EPS by 24c
• Calamp Corp. (CAMP) Misses Q2 EPS by 33c